Insider Transactions in Q1 2026 at Age X Therapeutics, Inc. (AGE)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Jan 14 2026	Randall Moreadith Chief Scientific Officer	SELL Open market or private sale	Direct	1,084 -100.0%	$2,168 $2.5 P/Share
Jan 14 2026	Randall Moreadith Chief Scientific Officer	BUY Exercise of conversion of derivative security	Direct	1,084 +50.0%	$0 $0.06 P/Share
Jan 13 2026	Randall Moreadith Chief Scientific Officer	SELL Open market or private sale	Direct	5,416 -100.0%	$10,832 $2.5 P/Share

Jan 13 2026	Randall Moreadith Chief Scientific Officer	BUY Exercise of conversion of derivative security	Direct	5,416 +50.0%	$0 $0.06 P/Share
Jan 08 2026	Randall Moreadith Chief Scientific Officer	SELL Open market or private sale	Direct	13,000 -100.0%	$26,000 $2.69 P/Share
Jan 08 2026	Randall Moreadith Chief Scientific Officer	BUY Exercise of conversion of derivative security	Direct	13,000 +50.0%	$0 $0.06 P/Share

Receive a notification when an Institution or Guru buys or sells AGE shares.

Notify only if

Value

Get notified when an Age X Therapeutics, Inc. insider buys or sells AGE shares.

Notify only if

Operation

Value

Type

Receive news related to AgeX Therapeutics, Inc.